Captain Polyplast Reports 76% Surge in FY25 Consolidated Net Profit; Net Profit Margin Expands to 10.8%

Mumbai (Maharashtra) [India], May 12: Captain Polyplast Limited (CPL, BSE: 536974), is one of the leading manufacturers and exporters of micro irrigation solutions, and has diversified its operations into the burgeoning solar EPC and polymer markets. The Company reported its Audited financials for Q4 FY25 and FY25.

Key Consolidated Financial Highlights

Q4 FY25

  • Total Income of ₹ 79.10 Cr, YoY growth of 13.33%
  • EBITDA of ₹ 9.65 Cr, YoY growth of 0.04%
  • EBITDA Margin (%) of 12.20%, YoY change of -162 BPS
  • Net Profit of ₹ 5.12 Cr, YoY growth of 2.00%
  • Net Profit Margin (%) of 6.47%, YoY change of -72 BPS
  • EPS of ₹ 0.90, YoY change of -5.26%

FY25

  • Total Income of ₹ 289.70 Cr, YoY change of -2.66%
  • EBITDA of ₹ 35.11 Cr, YoY change of -0.13%
  • EBITDA Margin (%) of 12.12%, YoY growth of 31 BPS
  • Net Profit of ₹ 31.23 Cr, YoY growth of 76.14%
  • Net Profit Margin (%) of 10.81%, YoY growth of 484 BPS
  • EPS of ₹ 5.54, YoY growth of 64.88%

Commenting on the performance, Mr. Ritesh Khichadia, a Whole Time Director of Captain Polyplast Limited, said, “We ended the year on a healthy note with top-line growth of 13.3% YoY in Q4 FY25. For the full year, we had two very different scenarios in both halves. In the first one, we faced a decline in revenue primarily due to challenges in the micro irrigation business on account of elections and extended monsoon. However, we saw a strong revival in the micro irrigation business in the H2.

Also, throughout the year, we witnessed strong momentum in the solar EPC vertical, especially in residential and rooftop industrial projects. We expanded our network to multiple states in solar EPC during the year and will continue the same in FY26 as well. Looking ahead, we are optimistic about the opportunities in both our core and emerging business segments. The micro irrigation industry is poised for sustained growth, driven by increasing awareness, government support, and the need for water-efficient solutions.

The PM Surya Ghar Yojna is providing a significant boost to residential rooftop projects which augurs well for our solar EPC vertical. We are also working towards a significant milestone with the new Ahmedabad manufacturing plant expected to commence before the end of H1 FY26. We remain committed to driving sustainable growth through product innovation, operational efficiency, and customer-centric solutions. With a solid foundation in place and strong industry tailwinds, Captain Polyplast is well-positioned to create long-term value.”

Q4 FY25 Key Business Highlights

Fundraising through warrants

Approved the allotment of 48,00,000 convertible warrants on a preferential basis to promoters and non-promoters. Total fund raised of ₹ 34.56 Cr

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More